Weixiao Dai
George Washington University(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Antibiotics Pharmacokinetics and Efficacy, Bacterial Identification and Susceptibility Testing, Pneumonia and Respiratory Infections
Most-Cited Works
- → Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials(2022)34 cited
- → Characteristics of community-acquired carbapenem-resistant Enterobacterales(2022)28 cited
- → Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial(2022)25 cited
- → Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group(2023)17 cited
- → Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia(2023)16 cited
- → A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection(2022)15 cited
- → The Data and Safety Monitoring Board: The Toughest Job in Clinical Trials(2023)15 cited
- → The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations(2023)13 cited
- → The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions(2023)9 cited
- → Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review(2023)6 cited